Insider · CIK 0001180763

GILL SIMBA

Reports to the SEC for 4 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001180763

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award	Director	AAward	+28K sh	$4.08	+$114K	28,000
2026-02-03	SERSerina Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+92K sh	—	—	92,000
2025-06-17	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	$4.79	+$120K	25,000
2024-06-26	FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award	Director	AAward	+16K sh	$5.52	+$88.3K	16,000
2024-04-15	SERSerina Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+295K sh	—	—	295,300
2023-11-08	Evelo Biosciences, Inc.S Sale	Director, President & CEO	SSale	−172 sh	$0.33	−$56.76	17,758
2023-11-07	Evelo Biosciences, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+1,172 sh	—	—	17,930
2023-11-07	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−1,172 sh	—	—	15,236
2023-09-28	Evelo Biosciences, Inc.S Sale	Director, President & CEO	SSale	−1,996 sh	$3.94	−$7,864.24	16,758
2023-09-27	Evelo Biosciences, Inc.Restricted Stock UnitsA Award	Director, President & CEO	AAward	+60K sh	—	—	60,000
2023-09-27	Evelo Biosciences, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+15K sh	—	—	18,754
2023-09-27	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−15K sh	—	—	45,000
2023-08-08	Evelo Biosciences, Inc.S Sale	Director, President & CEO	SSale	−342 sh	$9.51	−$3,252.42	3,754
2023-08-07	Evelo Biosciences, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+1,171 sh	—	—	4,096
2023-08-07	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−1,171 sh	—	—	16,408
2023-06-21	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2023-06-08	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+1M sh	—	—	1,000,000
2023-05-08	Evelo Biosciences, Inc.S Sale	Director, President & CEO	SSale	−3,537 sh	$0.13	−$443.894	58,512
2023-05-07	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+23.4K sh	—	—	351,563
2023-05-07	Evelo Biosciences, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+23.4K sh	—	—	62,049
2023-05-07	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−23.4K sh	—	—	351,563
2023-02-07	Evelo Biosciences, Inc.Restricted Stock UnitsA Award	Director, President & CEO	AAward	+375K sh	—	—	375,000
2023-02-07	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+1.13M sh	—	—	1,125,000
2022-09-13	FHTXFoghorn Therapeutics Inc.G Gift	Director	GGift	−47.9K sh	—	—	34,061
2022-09-12	FHTXFoghorn Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+82K sh	$0.73	+$59.9K	82,000
2022-09-12	FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−82K sh	—	—	107,188
2022-06-21	FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2022-01-19	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+300K sh	—	—	300,000
2021-07-13	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,530
2021-01-27	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+275K sh	—	—	275,000
2020-01-28	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+250K sh	—	—	250,000
2019-01-14	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+220K sh	—	—	220,000
2018-05-08	Evelo Biosciences, Inc.Stock OptionA Award	Director, President & CEO	AAward	+146K sh	—	—	145,869
2005-07-01	MAXYGEN INCEmployee Stock Option (right to buy)A Award	President	AAward	+87.5K sh	—	—	87,500
2005-07-01	MAXYGEN INCEmployee Stock Option (right to buy)A Award	President	AAward	+37.5K sh	—	—	37,500
2005-01-03	MAXYGEN INCEmployee Stock Option (right to buy)A Award	President	AAward	+37.5K sh	—	—	37,500
2005-01-03	MAXYGEN INCEmployee Stock Option (right to buy)A Award	President	AAward	+87.5K sh	—	—	87,500
2004-01-02	MAXYGEN INCEmployee Stock Option (right to buy)A Award	President	AAward	+75K sh	—	—	75,000
2003-01-17	MAXYGEN INCEmployee Stock Option (right to buy)A Award	President	AAward	+150K sh	—	—	—
2002-10-01	MAXYGEN INCEmployee Stock Option (right to buy)A Award	President	AAward	+39.4K sh	—	—	—
2002-07-01	MAXYGEN INCEmployee Stock Option (right to buy)A Award	President	AAward	+39.4K sh	—	—	—
2002-04-01	MAXYGEN INCEmployee Stock Option (right to buy)A Award	President	AAward	+39.4K sh	—	—	—
2002-01-18	MAXYGEN INCEmployee Stock Option (right to buy)A Award	President	AAward	+39.4K sh	—	—	—

Recent filings

Accepted (ET)
Jun 254
GILL SIMBA0001180763-26-000005
SEC(opens sec.gov)
Feb 174
GILL SIMBA0001180763-26-000002
SEC(opens sec.gov)
Jun 174
GILL SIMBA0001562180-25-004902
SEC(opens sec.gov)
Jun 284
GILL SIMBA0001562180-24-005359
SEC(opens sec.gov)
Apr 174
GILL SIMBA0001493152-24-015067
SEC(opens sec.gov)
Nov 84
GILL SIMBA0001694665-23-000176
SEC(opens sec.gov)
Sep 294
GILL SIMBA0001694665-23-000160
SEC(opens sec.gov)
Aug 94
GILL SIMBA0001694665-23-000135
SEC(opens sec.gov)
Jun 224
GILL SIMBA0001562180-23-005475
SEC(opens sec.gov)
Jun 124
GILL SIMBA0001694665-23-000081
SEC(opens sec.gov)
May 104
GILL SIMBA0001694665-23-000051
SEC(opens sec.gov)
May 104/A
GILL SIMBA0001694665-23-000046
SEC(opens sec.gov)
May 94
GILL SIMBA0001694665-23-000043
SEC(opens sec.gov)

Companies

Address

99 COOLIDGE AVENUE STE 500

WATERTOWN, MA, 02472